Clinicn Investigator, Asst Prf MGBCI Faculty Neuro Med Onc MGPO, Mass General Research Institute

Assistant Professor of Neurology Harvard Medical School

Assistant Neurologist Neurology-Neuro-Oncology, Massachusetts General Hospital

MD Medical College of Georgia 2014

deep learning; digital pathology; genomics; medical imaging; medical oncology; therapeutic resistance

I am a board-certified oncologist that leads a multi-disciplinary group in deep learning (DL)-computer vision and cancer genomics. Our prior work has applied end-to-end DL to data acquired in standard oncologic care (e.g., histopathology [H&E], CT, MRI) to accurately infer properties of the microenvironment (TME), and to discover new associations with therapeutic outcomes across multiple tumor types. To build upon this work, our group uses multi-modal DL to repurpose clinical data from large patient populations to identify and dissect new mechanisms underlying therapeutic resistance, which could have transformative impact for drug optimization.